Correction to: Ozanimod: A Review in Ulcerative Colitis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Works matching IS 00126667 AND DT 2022 AND VI 82 AND IP 12
Results: 12
1
2
Cadonilimab: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 12, p. 1333, doi. 10.1007/s40265-022-01761-9
- By:
- Publication type:
- Article
3
Eye Involvement and Management in Inherited Epidermolysis Bullosa.
- Published in:
- Drugs, 2022, v. 82, n. 12, p. 1277, doi. 10.1007/s40265-022-01770-8
- By:
- Publication type:
- Article
4
Correction to: Prevention and Treatment of Monkeypox.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
5
Acute Pancreatitis: Diagnosis and Treatment.
- Published in:
- Drugs, 2022, v. 82, n. 12, p. 1251, doi. 10.1007/s40265-022-01766-4
- By:
- Publication type:
- Article
6
Correction to: Tapinarof Cream 1%: First Approval.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
7
Correction: Estetrol/Drospirenone: A Review in Oral Contraception.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
8
Ozanimod: A Review in Ulcerative Colitis.
- Published in:
- Drugs, 2022, v. 82, n. 12, p. 1303, doi. 10.1007/s40265-022-01762-8
- By:
- Publication type:
- Article
9
Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis.
- Published in:
- Drugs, 2022, v. 82, n. 12, p. 1287, doi. 10.1007/s40265-022-01756-6
- By:
- Publication type:
- Article
10
Amubarvimab/Romlusevimab: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 12, p. 1327, doi. 10.1007/s40265-022-01759-3
- By:
- Publication type:
- Article
11
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
- Published in:
- Drugs, 2022, v. 82, n. 12, p. 1237, doi. 10.1007/s40265-022-01757-5
- By:
- Publication type:
- Article
12
Linzagolix: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 12, p. 1317, doi. 10.1007/s40265-022-01753-9
- By:
- Publication type:
- Article